Generation of dual-attribute iTNK cells from hPSCs for cancer immunotherapy.

Cell Rep Methods

Peking-Tsinghua Center for Life Sciences, The MOE Key Laboratory of Cell Proliferation and Differentiation, School of Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing 100871, China; Changping Laboratory, Beijing 102206, China. Electronic address:

Published: September 2024

Dual-attribute immune cells possess advantageous features of cytotoxic T cells and natural killer (NK) cells and hold promise for advancing immunotherapy. Dual-attribute cell types such as invariant natural killer T cells, induced T-to-NK cells, and cytokine-induced killer cells have demonstrated efficacy and safety in preclinical and clinical studies. However, their limited availability hinders their widespread application. Human pluripotent stem cells (hPSCs) offer an ideal source. Here, we generate dual-attribute induced T-NK (iTNK) cells from hPSCs, expressing markers of both cytotoxic T and NK cells. Single-cell RNA and T cell receptor (TCR) sequencing analyses reveal that iTNK cells expressed signature genes associated with both NK and T cells and displayed a diverse TCR repertoire. iTNK cells release cytotoxic mediators, exert cytotoxicity against diverse tumor cell lines, and inhibit tumor growth in vivo. By harnessing adaptive and innate immune responses, hPSC-derived iTNK cells offer promising strategies for cancer immunotherapy.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11440056PMC
http://dx.doi.org/10.1016/j.crmeth.2024.100843DOI Listing

Publication Analysis

Top Keywords

itnk cells
20
cells hpscs
12
cells
11
cancer immunotherapy
8
immunotherapy dual-attribute
8
natural killer
8
killer cells
8
itnk
5
generation dual-attribute
4
dual-attribute itnk
4

Similar Publications

Dual role of in T-cell malignancies.

Blood Sci

October 2024

Key Laboratory for Regenerative Medicine of Ministry of Education, Institute of Hematology, School of Medicine, Jinan University, Guangzhou, China.

The zinc finger transcription factor B-cell CLL/lymphoma 11B gene (, ) plays a crucial role in T-cell development, but its role in T-cell malignancies has not yet been definitively clarified. In the literature, 2 contradictory hypotheses on the function of exist. One suggests that functions as tumor suppressor gene, and the other suggests that functions as oncogene.

View Article and Find Full Text PDF

Generation of dual-attribute iTNK cells from hPSCs for cancer immunotherapy.

Cell Rep Methods

September 2024

Peking-Tsinghua Center for Life Sciences, The MOE Key Laboratory of Cell Proliferation and Differentiation, School of Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing 100871, China; Changping Laboratory, Beijing 102206, China. Electronic address:

Dual-attribute immune cells possess advantageous features of cytotoxic T cells and natural killer (NK) cells and hold promise for advancing immunotherapy. Dual-attribute cell types such as invariant natural killer T cells, induced T-to-NK cells, and cytokine-induced killer cells have demonstrated efficacy and safety in preclinical and clinical studies. However, their limited availability hinders their widespread application.

View Article and Find Full Text PDF

Human induced-T-to-natural killer cells have potent anti-tumour activities.

Biomark Res

March 2022

China-New Zealand Joint Laboratory of Biomedine and Health, State Key Laboratory of Respiratory Disease, Guangdong Provincial Key Laboratory of Stem Cell and Regenerative Medicine, Chinese Academy of Sciences Key Laboratory of Stem Cell and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.

Article Synopsis
  • Scientists are working on a new cancer treatment called adoptive cell therapy (ACT) that uses special T cells and natural killer (NK) cells to fight tumors, especially solid tumors, which are harder to treat.
  • They experimented with a gene-editing tool called CRISPR to change human T cells, which helped turn them into a new type of cell called induced T-to-natural killer cells (ITNKs) that can better attack cancer.
  • In early tests on patients with hard-to-treat cancers, these ITNKs were found to be safe and showed some positive effects, making them a promising option for future cancer therapies.
View Article and Find Full Text PDF

Thymocytes after T-lineage commitment develop in the T-cell pathway. However, in a recent study, Li et al. (2010) demonstrated that inducing to delete Bcl11b gene in these thymocytes, even in mature T cells turns these cells into natural killer (NK) cells during the culture.

View Article and Find Full Text PDF

T cells develop in the thymus and are critical for adaptive immunity. Natural killer (NK) lymphocytes constitute an essential component of the innate immune system in tumor surveillance, reproduction, and defense against microbes and viruses. Here, we show that the transcription factor Bcl11b was expressed in all T cell compartments and was indispensable for T lineage development.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!